Marshall Islands vs Suriname: Coverage of the human papillomavirus vaccine
Marshall Islands
49
in 2025
Suriname
47
in 2025
Marshall Islands rank
64th
Suriname rank
67th
Coverage of the human papillomavirus vaccine over time
- Marshall Islands
- Suriname
How they compare
Marshall Islands currently reports 49 against 47 in Suriname, a difference of 2.
The two have swapped places 5 times across 10 shared years of data; in 2016 it was Suriname ahead.
Marshall Islands ranks 64th and Suriname ranks 67th of 85 countries.
Across the 2 decades both report, Marshall Islands averaged higher in 1 and Suriname in 1.
Head to head by decade
| Decade | Marshall Islands | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.25 | 36 | 8.75 | Suriname |
| 2020s | 49.5 | 48.33 | 1.17 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Marshall Islands or Suriname?
- Marshall Islands, at 49 against 47 in Suriname as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Marshall Islands and Suriname?
- 2, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Suriname?
- 10 years are reported by both, from 2016 to 2025.
- How do Marshall Islands and Suriname rank globally for coverage of the human papillomavirus vaccine?
- Marshall Islands ranks 64th and Suriname ranks 67th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.